Clinical Trial Update: Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update comparing Exosurf Neonatal and Survanta for respiratory distress syndrome in newborns, spanning Phase 2 and Phase 3, with completed status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Respiratory Distress Syndrome of Newborn

Drugs mentioned

• Exosurf Neonatal (surfactant)
• SURVANTA (beractant)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Infant, Low Birth Weight | Phase 2, Phase 3 | Status: COMPLETED